(Reuters/CCTV) A leading Ebola researcher said on Tuesday that the experimental Ebola drug ZMapp has a good chance of curing people who are infected in the current Ebola outbreak in West Africa. ZMapp, co-developed by U.S. researchers and the Public Health Agency of Canada, is a cocktail of three monoclonal antibodies – extracted from tobacco plants – that is designed to bind to the protein of the Ebola virus, neutralizing the virus so it can’t cause further damage. According to a […]